AbemaciclibAbemaciclib, sold under the brand name Verzenio among others, is a medication for the treatment of advanced or metastatic breast cancers. It was developed by Eli Lilly and it acts as a CDK inhibitor selective for CDK4 and CDK6. Read from the Drugbox of the Wikipedia article Abemaciclib, revision 1369016405.

Property

Value

Formula

C27H32F2N8, 506.60 g/mol

Bioavailability

45 %

Protein binding

96.3 %

Elimination half-life

18.3 h

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.